1. Home
  2. NEXA vs COLL Comparison

NEXA vs COLL Comparison

Compare NEXA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXA
  • COLL
  • Stock Information
  • Founded
  • NEXA 1956
  • COLL 2002
  • Country
  • NEXA Luxembourg
  • COLL United States
  • Employees
  • NEXA N/A
  • COLL 197
  • Industry
  • NEXA Metal Mining
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXA Basic Materials
  • COLL Health Care
  • Exchange
  • NEXA Nasdaq
  • COLL Nasdaq
  • Market Cap
  • NEXA 1.2B
  • COLL 1.1B
  • IPO Year
  • NEXA 2017
  • COLL 2015
  • Fundamental
  • Price
  • NEXA $6.47
  • COLL $33.35
  • Analyst Decision
  • NEXA Sell
  • COLL Strong Buy
  • Analyst Count
  • NEXA 5
  • COLL 5
  • Target Price
  • NEXA $7.40
  • COLL $43.80
  • AVG Volume (30 Days)
  • NEXA 299.1K
  • COLL 478.2K
  • Earning Date
  • NEXA 02-19-2025
  • COLL 02-20-2025
  • Dividend Yield
  • NEXA N/A
  • COLL N/A
  • EPS Growth
  • NEXA N/A
  • COLL 757.11
  • EPS
  • NEXA N/A
  • COLL 2.16
  • Revenue
  • NEXA $2,655,440,000.00
  • COLL $599,245,000.00
  • Revenue This Year
  • NEXA $5.90
  • COLL $13.20
  • Revenue Next Year
  • NEXA $2.24
  • COLL $17.63
  • P/E Ratio
  • NEXA N/A
  • COLL $15.47
  • Revenue Growth
  • NEXA N/A
  • COLL 9.62
  • 52 Week Low
  • NEXA $5.10
  • COLL $28.39
  • 52 Week High
  • NEXA $9.61
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • NEXA 38.29
  • COLL 62.31
  • Support Level
  • NEXA $5.97
  • COLL $32.29
  • Resistance Level
  • NEXA $7.55
  • COLL $33.99
  • Average True Range (ATR)
  • NEXA 0.65
  • COLL 1.29
  • MACD
  • NEXA -0.15
  • COLL 0.51
  • Stochastic Oscillator
  • NEXA 14.21
  • COLL 87.40

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: